News & Updates

Product Highlight - SOLIQUA

16 Jun 2021

Insulin glargine + Lixisenatide 100 u/mL + 50 mcg/mL solution for injection (3 mL pre-filled pen); 100 u/mL + 33 mcg/mL solution for injection (3 mL pre-filled pen)

Product Highlight - SOLIQUA

16 Jun 2021

Product Highlight - TOUJEO

16 Jun 2021

Insulin Glargine 300 units/mL pre-filled pen

Product Highlight - TOUJEO

16 Jun 2021

Metformin reduces risk of BCC development

15 Jun 2021

Treatment with metformin, even at low doses, appears to lower the risk of basal cell carcinoma (BCC) development, results of a recent study have shown.

Metformin reduces risk of BCC development

15 Jun 2021

Lower LDL-C levels linked to decreased insulin secretion

15 Jun 2021 by

Insulin secretion is reduced in case of lesser low-density lipoprotein cholesterol (LDL-C), which possibly explains the deteriorated glycaemic control in response to cholesterol-lowering drugs, suggests a study.

Lower LDL-C levels linked to decreased insulin secretion

15 Jun 2021

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

15 Jun 2021

New drug applications approved by US FDA as of 01-15 June 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

15 Jun 2021

Henagliflozin-metformin combo a new therapeutic alternative for T2D

14 Jun 2021 by

Adding the sodium-glucose cotransporter-2 (SGLT2) inhibitor henagliflozin to metformin led to significant improvements in glycaemic control, body weight, and blood pressure (BP) in Chinese patients with type 2 diabetes (T2D) with insufficient response to metformin alone, a phase III study has shown.

Henagliflozin-metformin combo a new therapeutic alternative for T2D

14 Jun 2021

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients

13 Jun 2021

Patients with type 1 diabetes (T1D) born to mothers with a history of stroke are at heightened risk of developing haemorrhagic stroke, a study reports.

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients

13 Jun 2021

High serum pentosidine linked to sarcopenia in T2DM

12 Jun 2021

In middle-aged and elderly men with type 2 diabetes mellitus (T2DM), elevated serum concentrations of pentosidine, an advanced glycation end-product, aggravate the risk of sarcopoenia, a new study has found.

High serum pentosidine linked to sarcopenia in T2DM

12 Jun 2021

Finerenone reduces risk of new-onset AF in patients with CKD, T2D

12 Jun 2021 by

Treatment with finerenone led to a significantly reduced risk of new-onset atrial fibrillation (AF) in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), according to the FIDELIO-DKD* trial presented at the ACC.21 Virtual Meeting.

Finerenone reduces risk of new-onset AF in patients with CKD, T2D

12 Jun 2021

Could UDCA after bariatric surgery reduce gallstones?

11 Jun 2021 by

In obese patients without gallstones, a 6-month treatment course of ursodeoxycholic acid (UDCA) following bariatric surgery may reduce their likelihood of developing symptomatic gallstones, according to findings of the UPGRADE trial from The Netherlands presented at DDW 2021.

Could UDCA after bariatric surgery reduce gallstones?

11 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Product Highlight - SOLIQUA

Product Highlight - SOLIQUA

Product Highlight - TOUJEO

Product Highlight - TOUJEO

Metformin reduces risk of BCC development

Metformin reduces risk of BCC development

Lower LDL-C levels linked to decreased insulin secretion

Lower LDL-C levels linked to decreased insulin secretion

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

Henagliflozin-metformin combo a new therapeutic alternative for T2D

Henagliflozin-metformin combo a new therapeutic alternative for T2D

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients

High serum pentosidine linked to sarcopenia in T2DM

High serum pentosidine linked to sarcopenia in T2DM

Finerenone reduces risk of new-onset AF in patients with CKD, T2D

Finerenone reduces risk of new-onset AF in patients with CKD, T2D

Could UDCA after bariatric surgery reduce gallstones?

Could UDCA after bariatric surgery reduce gallstones?